PA
Paul Andrew Moore sold $1M of ZYME stock
Paul Andrew Moore, Chief Scientific Officer of Zymeworks Inc. (ZYME), sold 39,741 shares of ZYME stock worth $1M, per an SEC Form 4 filed Nov 16, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 13, 2026, 3 days before it was made public.
ZYME has moved +0.0% since the trade date, from $26.24 to $26.24 (Nov 13, 2026 close).
- Traded
- Nov 13, 2026
- Disclosed
- Nov 16, 2026
- Filing delay
- 3 days
- Price since
- +0.0%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4